Navigation Links
Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN), today announced top-line results of its "Safer Aspirin" PA 325 proof-of-concept study conducted during the fourth quarter of 2006. PA 325 is a patented formulation of 325mg of aspirin surrounded by a 20mg coating of an immediate release formulation of a proton pump inhibitor.

The PA 325, 28 day study, involved two groups of 40 subjects over the age of 50. Each subject was treated with either once a day commercially available enteric coated aspirin 325mg or PA 325. The primary endpoint was gastrointestinal damage as measured by the Lanza scoring system used in our previous PN studies. The results were highly significant with 10 percent of the PA group having Lanza 3 or 4 gastrointestinal damage, whereas 57.5percent of the enteric coated aspirin group had this level of gastrointestinal damage. Furthermore, no ulcers were seen in the PA group, while 20 percent of subjects in the enteric coated aspirin 325mg group developed a gastric ulcer during the study. This difference was also statistically significant.

Dr. John R. Plachetka, chairman, president and chief executive officer stated, "The data from this first clinical study with PA 325 is very encouraging."

About POZEN

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for the proposed product candidate *Trexima*_ combining sumatriptan, formulated with RT Technology_, and naproxen sodium in a single tablet for the acute treatment of migraine, which is currently under review by the United States Food and Drug
'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pozen Announces Positive Outcome for
(Date:5/5/2015)... and ST. LOUIS , May ... pressure or high cholesterol may achieve better health outcomes ... according to early results of a unique program conducted ... ESRX ). "Pharmacists are one of the ... interactions with our members presents enormous opportunities to positively ...
(Date:5/5/2015)... 2015 Big Market Research presents a detailed ... Europe , ( France , Germany ... , UK) and Japan . Current scientific views ... provides the 5-year test volume and sales forecasts by country for ... Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed ...
(Date:5/5/2015)... 2015 E-QURE (Electric Quick Ulcer ... premier provider of innovative medical devices in the field ... to shareholders and the investment community, covering 2014 - ... the proprietary Bioelectrical Signal Therapy™ (BST) Device for advanced ... as well as its plans for commercialization and sale ...
Breaking Medicine Technology:SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 42015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 2E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 3E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 4E-QURE Corp. Issues 2014 - 2015 Update to Shareholders 5
... Holdings Corporation ("Select") (NYSE: SEM ), the parent ... received notice of the exercise of the underwriters, over-allotment ... common stock at a price per share of $10.00, ... subject to customary closing conditions. The over-allotment option was ...
... , HOFFMAN ESTATES, Ill., Oct. 23 While preparing ... only is Kmart a store for holiday gift buying, ... of health and wellness needs during winter and throughout ... and rewards to encourage customers to manage their wellness ...
Cached Medicine Technology:Select Medical Holdings Corporation Announces Exercise of Underwriters' Option to Purchase Additional Shares 2Discover Kmart Pharmacy for Wellness Needs 2Discover Kmart Pharmacy for Wellness Needs 3
(Date:5/5/2015)... (PRWEB) May 05, 2015 AxoGen, ... focused on the $1.6 billion peripheral nerve repair market, ... quarter ended March 31, 2015 compared to $3.14 million ... continued adoption of our proprietary portfolio of nerve repair ... and AxoGuard® Nerve Protector – and our solid sales ...
(Date:5/5/2015)... The 2015 Crystal Ball, hosted by the Hepatitis ... outreach and patient advocacy programs. The gala evening included dancing, ... hundreds of supporters. , The 2015 gala was dedicated to ... virus (HBV) by Dr. Baruch S. Blumberg, who passed away ... for his discovery of the virus in 1976. He and ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Baptist Medical ... Commission on Cancer (CoC) of the American College of ... program must meet more than 30 Commission on Cancer ... a survey process, and maintain levels of excellence in ... When patients choose to seek care locally at a ...
(Date:5/5/2015)... " QuickPick Travel ” was featured on NewsWatch as ... small, medium, and large businesses making an impact in their ... expert, conducted the business review and shared with viewers how ... weeks of vacation for free. , Vacations are a sought-after ... world. And when people are preparing for vacations, they’re used ...
(Date:5/5/2015)... 2015 ProTexting, LLC – a ... deploy Mobile Engagement Campaigns and other Mobile solutions, introduces ... can now leverage the power of Mobile Marketing to ... subscribers’ e-mail addresses into the Constant Contact Platform. , ... the growing trend of multi-channel marketing would become more ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... found twice the success rate when parents took part in ... play a significant role in the treatment of teens with ... involved in a treatment program, the percentage of teens able ... months doubled. , "Families have often been seen as part ...
... Signalife, Inc. (Amex:,SGN) has committed to deploy Fidelity 100 ... for testing of sudden cardiac death and,cardiovascular disease, events ... Profit Foundation ("AFL"), through mobile centers though which AFL,will ... its founders and,members some of the world,s greatest living ...
... Doctors and Patients More Precisely Stage, Diagnose ... and Treat ... (LCA), the only US-based organization devoted exclusively to,patient support and advocacy ... presentation by lead investigators of the,International Association for the Study of ...
... Mutual Life,Insurance Company (MassMutual) today announced the ... president of Corporate Human Resources. The,announcement was ... president and,chief administrative officer of MassMutual and ... LLC. Palermino, 54, joined MassMutual in ...
... part in therapy , , TUESDAY, Sept. 4 (HealthDay News) -- ... teens with bulimia, a new study has found. , When ... teens able to abstain from the eating disorder,s binge-purge pattern ... as part of the problem, rather than part of the ...
... patients with depression who are treated by primary care ... according to a new RAND Corporation study. , Physicians ... of the 20 measures of quality that researchers examined ... of the treatment recommendations studied, according to the report ...
Cached Medicine News:Health News:Parental Involvement Key to Battling Bulimia 2Health News:Parental Involvement Key to Battling Bulimia 3Health News:Signalife to Deploy Fidelity 100 Heart Monitors for AFL 2Health News:Signalife to Deploy Fidelity 100 Heart Monitors for AFL 3Health News:LCA Hails International Investigators Studying Lung Cancer 2Health News:MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources 2Health News:Parental Involvement Key to Battling Bulima 2Health News:Parental Involvement Key to Battling Bulima 3Health News:Study finds primary care depression treatment often does not follow quality guidelines 2Health News:Study finds primary care depression treatment often does not follow quality guidelines 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: